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Abstract  
Heparin and heparan sulfate (HS) by nature contain multiple isomeric structures, which are 
fundamental for the regulation of biological processes. Here we report the use of a porous 
graphitised carbon (PGC) LC-MS method with effective separation and sensitivity to separate 
mixtures of digested HS oligosaccharides. Application of this method allowed the separation of 
oligosaccharide mixtures with various degree of polymerization (dp) ranging from dp4 to dp8, 
two dp4 isomers that were baseline resolved, four dp6 isomers and the observation of a dp3 
oligosaccharides. PGC LC-MS of complex mixtures demonstrated that compounds eluted from 
the column in decreasing order of hydrophilicity, with the more highly sulfated structures eluting 
first. Our data indicates that sulfation levels, chain length and conformation all effect elution 
order. We found that PGC’s resolving capabilities of the dp4 and dp6 isomeric structures makes 
this methodology particularly useful for the sequencing of HS saccharides, since the lack of 
contaminating isomeric structures provides unambiguous structural assignments from the 
MS/MS data. Collectively this work demonstrates that PGC column-based methods are powerful 
tools for enhanced separation and analysis of heterogeneous mixtures of HS saccharide species. 
 
Introduction 
Heparin and HS are composed of repeating disaccharide units, containing an alternating 
arrangement of an uronic acid sugar (either glucuronic or iduronic acid) and a glucosamine 
residue. The uronic acid residue can be O-sulfated at the carbon 2 position, whereas the 
glucosamine can be 6-O-sulfated and rarely 3-O-sulfated; in addition, the N-position can be 
occupied by a sulfate, acetate or un-modified. During biosynthesis these modifications are 
incomplete, resulting in complex cell and tissue-specific variations in the structural patterns 
generated, including isomeric structures1-3. This variability is responsible for the protein 
regulatory properties of HS and has been the focus of recent research4-6. This complexity also 
gives rise to significant challenges for the separation and sequencing of saccharides derived from 
HS. 
Various methods for separation of HS saccharides by chromatography have been developed, 
however, isolation of a pure saccharide with a single, defined structure is still challenging. Often, 
size exclusion chromatography (SEC) is the initial methodology used, to produce size defined 
separations typically aimed at isolating structures with similar numbers of monosaccharide units 
(degree of polymerization, dp). SEC has also been coupled with mass spectrometry to profile 
each fraction1, 7-8. Since HS saccharides are predominantly negatively charged, SAX (strong 
anion exchange) and VSCTA (volatile salt cetyltrimethylammonium)-SAX are chromatography 
methods with the highest resolving power for heparin and HS separation and are often used in 
tandem to achieved greater resolution9-10. However, neither chromatography method is 
compatible with LC-MS11. 
Reverse phase ion pairing (RP-IP) chromatography, commonly used for protein12 and peptide13 
separation, has also been effectively utilized for HS saccharides through the addition of an ion 
pairing agent, such as triethylamine14-15. RP-IP provides the resolution and separation allowing it 
to be the first method to be coupled with MS, enabling LC-MS analysis of HS 
oligosaccharides16. However, a drawback of this method is that the ion-pairing reagent causes 
signal suppression and ion source contamination. Hydrophilic interaction liquid chromatography 
(HILIC) is the most recent method to be applied, separating on the basis of hydrophilicity. Since 
HS is a particularly hydrophilic molecule with multiple polar side groups (sulfates, carboxylates 
and hydroxyls), HILIC is a good choice for the separation of these compounds. It has been used 
in both offline and online modes to separate a wide range of structures including O-glycans17, N-
glycans18, GAG disaccharides19 and GAG oligosaccharides20-21. HILIC is also the most recent 
technique to be coupled with MS for these applications22-23; although it lacks the resolution of 
SAX and RP-IP, it has higher sensitivity and is MS compatible. 
PGC has been used for decades in the analysis of small oligosaccharides, in particular O-linked 
glycans24 and N-linked glycans25-26.The hydrophobic attributes of graphite mean that the columns 
behave in a similar manner to reverse phase material; the electronic properties are due to the 
polarizable surface causing a charge-induced dipole with the retention of negatively charged 
molecules27. PGC can act as both an oxidising and reducing reagent towards analytes, whereby 
its current state can affect the retention time and peak shape of the separated analytes. Altered 
analyte retention generally results from PGC contamination, thus requiring regular backflush 
with strong acids / bases and solvents (tetrahydrofuran, acetone, trifluoroacetate, hydrochloric 
acid and sodium hydroxide) as part of normal maintance28-29. Graphite can retain many glycan 
structures, and has been demonstrated to have high resolving capacity including separating α and 
β anomers26, 30-31. The main advantage of this technique is that it uses volatile buffers, usually in 
the presence of acetonitrile and so can be readily coupled with MS. This has also been shown to 
effectively separate charged oligosaccharides, such a chondroitin sulfate32, keratan sulfate, 
heparin and HS disaccharides30. 
Here, we describe for the first time the separation of HS oligosaccharide digests by PGC LC-MS. 
The low concentration of volatile ammonium bicarbonate causes little source contamination, 
increased ion sensitivity and sulfate protection33. Our data highlights the advantages of PGC LC-
MS for separation and purification of complex mixtures of HS oligosaccharides (including 
isomeric structures) with good sensitivity, establishing this methodology as a valuable tool for 
HS analysis.  
 
Experimental 
Materials and Reagents. Porcine mucosal heparan sulfate (PMHS) (Celsus Laboratories, 
Cincinnati, OH) was digested with recombinant heparinase III obtained from IBEX Technologies 
(Montreal, Canada). HPLC-grade water (Chromasolv, VWR, Radnor, Pennsylvania) was used 
throughout. All other reagents were of HPLC grade (Sigma-Aldrich, St Louis, MO).  
Depolymerisation of HS: Heparan sulfate (50 mg) was reconstituted in 300 µl of lyase buffer 
(100 mM sodium acetate, 10 mM calcium acetate), and digested using 120 mU of heparinase III 
for 24 hrs at 37 oC.  
SEC separation. SEC separations were performed on an Äkta P-900 FPLC system (GE 
Healthcare, Buckinghamshire, UK) using a XK16 column packed with Superdex 30 (30 mm x 
200 cm, bead size 34µm) using UV-spectrophotometric detection at 232 nm. Digested PMHS 
(50 mg/ml, 1.0 ml) was injected onto the column and separated using 0.5 M ammonium 
bicarbonate eluent at a flow rate of 0.5 ml/min. Fractions (0.5 ml) from each peak were pooled 
and repeatedly freeze dried using water until all the ammonium bicarbonate was lyophilized. 
Strong Anion-Exchange Chromatography (SAX). SAX separations were performed on a 
Shimadzu SPD 10A system (Manchester, UK) with a Propac PA1 column (4.6 mm x 250 mm, 5 
µm bead size (Thermo Scientific, Waltham, Massachusetts), with a UV-visible 
spectrophotometric detector. Eluent A was HPLC grade water and eluent B was 2.0 M NaCl. The 
elution profiles were monitored with an absorbance at 232 nm. A 2 mg dp4 SEC fraction was 
injected, and eluted with a linear gradient of 0-70 % B in A over 120 mins using a flow rate of 1 
ml/min at a temperature of 40 oC.  
PGC on-line mass spectrometry using an ion trap instrument.  
Online LC-MS was performed using an Agilent Technologies 1100 series LC system coupled to 
an Agilent Technologies MSD-XCT Plus Ion Trap mass spectrometer (Agilent Technologies, 
Palo Alto CA). Eluent A was HPLC grade water with 10 mM ammonium bicarbonate, eluent B 
was 80 % acetonitrile with 10 mM ammonium bicarbonate and eluent C HPLC grade water, 0.1 
% acetic acid. The porous graphitised carbon Protecol capillary column (100 x 0.32 mm, 5 µm, 
SGE, Melbourne, Australia) was equilibrated in eluent A and samples of varying concentrations 
were injected and subjected to a linear gradient 0-40 % B in A (v/v) over 40 minutes at a flow 
rate of 4 µl/min.  The column was regenerated with a 10 min wash cycle using 100 % eluent C 
followed by equilibration in eluent A (10 min). Elution into the ESI electrospray source was 
achieved at a flow rate of 4 µl min-1and heated to 270 oC. The negative ion mass spectrum of the 
sample was recorded using a spray voltage of 3.5 kV. The PGC column was left in buffer B 
overnight and between runs. 
PGC on-line mass spectrometry using a Q-TOF instrument. 
Online LC-MS of Arixtra was performed using a Waters Q-TOF Micro (Manchester, UK). 
Eluent A was HPLC grade water with 20 mM ammonium bicarbonate, eluent B was 80 % 
acetonitrile with 20 mM ammonium bicarbonate and eluent C was HPLC grade water, 0.1 % 
acetic acid. The porous graphitised carbon Hypercarb column (100 mm x 4.6 mm, 5 µm) was 
equilibrated in eluent A and samples of varying concentrations were injected and subjected to a 
linear gradient 0-40 % B in A (v/v) over 40 minutes at a flow rate of 0.3 ml/min. The column 
was regenerated with a 10 min wash cycle using 100 % eluent C followed by equilibration in 
eluent A (10 min). Elution into the ESI electrospray source was achieved at a flow rate of 300 µl 
min-1 and heated to 270 oC. The negative ion mass spectrum of the sample was recorded using a 
spray voltage of 2200 V. The PGC column was left in buffer B overnight and between runs.  
Off-line mass spectrometry. Each sample was infused into the nano-electrospray source of the 
mass spectrometer (Waters Q-TOF Micro, Manchester, UK) at a flow rate of 50 µl h-1, via a 1 
µm tip. The negative ion mass spectrum of the sample was recorded using a spray voltage at 
2200 V, sample voltage at 20V, extraction cone voltage at 1 V and collision energy at 3 V. Each 
sample was at a final concentration of 5 pmol/µl in water/acetonitrile (50:50, v/v). MS/MS was 
performed on selected masses, using the same conditions with the exception of the collision 
energy, which ranged from 3 V – 30 V.  
Data Interpretation. Glycoworkbench was used to create schematic oligosaccharide structures. 
A manually generated spreadsheet file (excel) of each structure was calculated for 1 glycosidic 
bond cleavage and validated with an example structure using Glycoworkbench. GWP files were 
exported from Glycoworkbench and submitted with Agilent file exported peak lists of generated 
data to the UniCarb-DB database (available in next version at http://unicarb-
db.org/references/342). 
 
Results and Discussion 
Initial separation of HS digested oligosaccharides.  
PMHS was digested using heparinase III and its oligosaccharide products were separated by 
preparative scale SEC on a Superdex 30 column (Figure S-1)11. Fractions corresponding to each 
peak were collected and subjected to a brief screening by offline MS (data not shown) to 
ascertain the average size of its constituent saccharides, calculated from the two most intense 
ions. Selected SEC fractions were either subject to PGC LC-MS as oligosaccharide mixtures or 
further purified through SAX and then subjected to PGC LC-MS as demonstrated in the 
workflow in Figure 1. Previous studies demonstrated the utility of PGC LC-MS for examining 
HS disaccharides30. Chromatography and LC-MS methodologies have been used to identify HS 
disaccharide changes in disease models34-35. However, biological information gained from 
disaccharide analysis is limited, since longer HS oligosaccharides are required to incur biological 
effects23, 36-37. To get insight into these larger oligosaccharides, PGC LC-MS was used to 
separate SEC oligosaccharide fractions (Base peak chromatograms in Figures 2a, 2b, and 2c) and 
Arixtra (Figure S-2). Each ion from the SEC fractions was identified using the combinatorial 
generated database of possible dp4, dp6 and dp8 (Tables S-1, S-2, and S-3) generated using 
Glycoworkbench38 and relative oligosaccharide abundances are displayed as bar charts (Figures 
S-3 to S-6). SEC peak A (Figure S-1) contained dp4’s with 3-4 sulfate groups, dp6’s with 0-4 
sulfate groups and a dp8 with 0 sulfate groups (Figure 2a, Table S-1 and Figure S-3). SEC peak 
B (Figure S-1) contained dp6’s with 1-5 sulfate groups and dp8’s with 0-2 sulfate groups (Figure 
2b, Table S-2 and Figure S-4). SEC peak C contained dp6’s with 3-5 sulfate groups and dp8’s 
with 0-5 sulfate groups (Figure 2c, Table S-3 and Figure S-5). Analysis of each SEC fraction did 
show low abundant oligosaccharides containing the rare free amines, which could either be a 
result of heparin processing or part of the native structure. A characteristic of the graphite 
column for oligosaccharide separation and elution is hydrophilicity. It was observed that higher 
levels of sulfation within each dp eluted earlier than lower levels. Analysis of identified ions 
from each fraction indicated that PGC provided isomeric separation of heparan sulfate 
oligosaccharides, which was further evaluated. 
 
Analysis of dp4 HS saccharides by PGC LC-MS. 
A dp4 SEC fraction (Figure S-1, peak A) was subjected to further orthogonal separation by SAX 
ProPac PA1 chromatography (Figure S-7). Two peaks, D and E (Figure S-7) were selected for 
analysis via PGC LC-MS to determine their structural sequence and purity. LC-MS of peak D 
displayed two peaks (peaks F and G) both with an [M – H]- of m/z 795 (Figures 3a and 3b) 
corresponding to a dp4 + 1Ac + 1SO3. MS/MS performed on the parent ions from the isomers 
generated unique product ion spectra for oligosaccharide sequencing (Figures 3c and 3d). Only 
two sequence combinations for m/z 795 [M – H]- exist; ΔUA – GlcNS – UA – GlcNAc and ΔUA 
– GlcNAc – UA – GlcNS, both showing different signal intensities of B, Y, C and Z product ions 
(Figures 3d and 3e). Each structure was deduced from these fragments (with only one cross ring 
cleavage and no sulfation loss) (Tables S-5 and S-6). Structure F, eluting at 18 minutes, displays 
a large proportion of B, Y, C and Z ions corresponding to the sequence ΔUA – GlcNS – UA – 
GlcNAc (Table S-5 and Figure 3c), whereas, structure G, eluting at 21 minutes, displays B, Y, C 
and Z ions of the structure ΔUA – GlcNAc – UA – GlcNS (Table S-6 and Figure 3d). Although 
both oligosaccharides have some isomeric product ions, the ions B3 (m/z 574), and Y2 (m/, 396) 
are unique to peak F (Figure 3c and Table S-5) and B3, (m/z 536), Y1 (m/z 258), and C3 (m/z 554) 
are unique to peak G (Figure 3d and Table S-6). Baseline resolution observed in two isomeric 
oligosaccharide structures proved the capability and the value of PGC LC-MS. LC-MS/MS of 
SAX separated peak E (Figure S-2) displayed a single peak (PGC - peak H) with an [M-2H]2- of 
m/z 477 (Figure 3b) corresponding to a dp4 + 1Ac + 3SO3, which has 12 theoretical isomeric 
structures (Tables S-7 to S-18). The MS/MS performed on peak H (Figure 3e) showed the 
product ions B1 (m/z 157), B2 (m/z 398), B3 (m/z 654), C2 (m/, 416), Y1 (m/z 300), Z1 (m/z 282), 
Z2 (m/z 538) and Z3 (m/z 779) represented nearly a full set of B, Y, C and Z ions concluding that 
the structure has the sequence of ∆UA – GlcNS – UA2S – GlcNAc6S (Table S-7 and Figure 3e). 
All products ions were assigned using Domon and Costello nomenclature39. 
 
Separation of dp6 HS structures using PGC LC-MS 
Isomeric structures are a prominent feature in HS, due to characteristic repeating disaccharide 
units with multiple locations for sulfate group modifications. The close chemical resemblance 
between HS oligosaccharide isomers provides a separation challenge for columns currently used 
for this application. Columns that have the greatest resolving capabilities require high levels of 
salt incompatible with LC-MS. Therefore, a tandem separation approach is advantageous, where 
the last step would be a low salt high resolution LC-MS method. To investigate the isomeric 
separation capabilities of PGC, a complex SEC dp6 mixture was subjected to PGC LC-MS 
analysis. The EIC (extracted ion chromatogram) of [M – 2H]2- ion of m/z 645.5 corresponding to 
a dp6 + 1Ac + 3SO3 from fraction B (SEC separation Figure S-1 and base peak chromatogram 
from PGC LC-MS in Figure 2b), showed the separation of four of isomeric structures (Figure 
4a). The MS/MS spectra performed on each structure indicated that they were different isomers 
(Figures 4b–4e), where each fragment spectrum showed different signal intensities of B, Y, C 
and Z product ions (Figures 4b-4e). To interpret the spectra we used biosynthetic rules to build a 
virtual library (Tables S-19 to S-37). It must therefore consist of one UA – GlcNAc, and two UA 
– GlcNS, and one additional O-sulfate, as free amines would be only be observed in low 
abundant structures. With these constraints 18 structures are possible for a single sulfate position, 
excluding differences in glucuronic and iduronic acid, and the rare free amine and 3-O-sulfate. 
Only intact product ions (no sulfate loss) were taken into consideration as these were the most 
informative (Tables S-19 to S-37). Fragment ions represented in Tables S-19 to S-37 are only of 
a single glycosidic cleavage. However, by having two glycosidic cleavages present it was 
possible to obtain nearly all product ions for all oligosaccharide sequences, albeit with varying 
intensities for isomeric structures40. Therefore, the assumption was made that a single glycosidic 
cleavage would was more likely than internal glycosidic bond fragments. Although it should be 
noted that this may not always be the case, with some understanding that N-sulfation can be 
prone to cross-ring cleavage41-45. Based on this information the oligosaccharide sequence eluting 
at 18 mins is ∆UA2S - GlcNS - UA - GlcNS - UA - GlcNAc (Figure 4b, Table S-19). Close to a 
full set of Y ions; Y2 (m/z 396) (UA – GlcNAc), Y3 (m/z 637) (GlcNS – UA – GlcNAc), Y4 (m/z 
813) (UA – GlcNS – UA – GlcNAc) and Y5 (m/z 526) (GlcNS – UA – GlcNS – UA – GlcNAc) 
were observed, with some complementary B and C ions; B2 (m/z 478) (ΔUA2S – GlcNS), C2 
(m/z 496) (ΔUA2S – GlcNS –) and B4 (m/z 447) (ΔUA2S – GlcNS – UA – GlcNS). The 
interpretation of the oligosaccharide eluting at 20 mins with 6 assigned fragment ions indicated 
that this was a mixture of two isomers in that peak. What appeared to be the dominating isomer 
was the ΔUA2S – GlcNS – UA – GlcNAc – UA – GlcNS structure based on the fragments Y3 
(m/z 637) (GlcNAc – UA – GlcNS), Y5 (m/z 526) (GlcNS – UA – GlcNAc – UA – GlcNS), Z2 
(m/z 416) (UA – GlcNS), Z3 (m/z 619) (GlcNAc – UA – GlcNS), Z5 (m/z 517) (GlcNS – UA – 
GlcNAc – UA – GlcNS), C2 (m/z 496) (ΔUA2S – GlcNS) (Figure 4c and Table S-25). The 
presence of the second isomer ΔUA2S – GlcNS – UA – GlcNS – UA – GlcNAc (Table S-19 and 
Table S-25) was concluded due to the presence of Z2 (m/z 378) (UA – GlcNAc), which was 
likely to be a contaminant from the adjacent peak eluting at 18 minutes. The structure eluting at 
21 minutes (Figure 4d and Table S-20) was interpreted as ΔUA – GlcNS6S – UA – GlcNS – UA 
– GlcNAc. The important ions to deduce this structure was C2 (m/z 496) (ΔUA – Glc6SNS) and 
Z4 (m/z 795) (UA – GlcNS – UA – GlcNAc), confirming the positions of the O-sulfates, with 
other ions complementary to the sequence Z2 (m/z 378) (UA – GlcNAc), Y2 (m/z 396), Z3 (m/z 
619) (GlcNS – UA – GlcNAc), Y4 (m/z 813) (UA – GlcNS – UA – GlcNAc). The structure 
eluting at 22 minutes shows that the sequence is ΔUA – GlcNS – UA – GlcNAc – UA – 
GlcNS6S (Figure 4e and Table S-30). The C2 (m/z 416) (ΔUA – GlcNS –), C3 (m/z 592) (ΔUA – 
GlcNS – UA –), C4 (m/z 795) (ΔUA – GlcNS – UA – GlcNAc –), B3 (m/z 574) (ΔUA – GlcNS – 
UA), B4 (m/z 777) (ΔUA – GlcNS – UA – GlcNAc), B5 (m/z 476) (ΔUA – GlcNS – UA – 
GlcNAc – UA), Y3 (m/z 717) (GlcNAc – UA – GlcNS6S) and Z2 (m/z 496) (UA – GlcNS6S) 
ions support the final sequence.  
 
Atypical structures identified using PGC LC-MS 
Analysis of heparinase produced products has led to the general view that oligosaccharides with 
odd-numbers of monosaccharides are rare, since these enzymes only cleave between 
glucosamine and uronic acid46. SEC fractions derived from HS by heparinase depolymerisation 
will be expected to contain a variety of oligosaccharides consisting of varying lengths and 
sulfation, including these rare oligosaccharides7. An example of one of these structures was seen 
by PGC LC-MS of the fraction M (Figure S-1 and Figure 5a). PGC LC-MS of fraction M from 
SEC (Figure S-1) appeared to consist of an odd-number monosaccharide unit oligosaccharide 
(Figure 5a and Table S-4), with one of the structures present producing an [M – H]-  precursor 
ion of m/z 592.1 (Figure 5a), which corresponds to a dp3 + 1SO3 group. The nearly full set of B, 
Y, C and Z ions from its MS/MS spectra confirmed that this structure has the sequence ΔUA – 
GlcNS – UA (Table S-38 and Figure 5b). This structure is consistent with trisaccharide structures 
observed previously as products from heparinase digests7. One possibility is that the dp3 
fragment may have resulted from heparinase III digestion of the linker region, whilst a further 
and perhaps more likely possibility is that the manufacturing and chemical processing of porcine 
mucosal HS (as a by-product of heparin production) has resulted in smaller fragments, which can 
be heparinase III digested leaving some tri-saccharides products.  
 Oligosaccharide recovery from the PGC column. 
Graphite has hydrophobic properties similar to that of a reverse phase material, and electronic 
properties that make it desirable for separation of sulfated oligosaccharides. The polarizable 
surface causes charge induced dipoles, and the oxidizing and reducing capabilities towards an 
analyte required an assessment of oligosaccharide yields from the PGC column. A purified 
heparin lyase digested dp6 + 8SO3
9-10 was used to assess PGC oligosaccharide recovery using 
UV detection (Figure S-8). The recovery yield of the dp6 + 8SO3 calculated from peak area was 
96 % (Figure S-8). 
 
Conclusions 
Here we demonstrate that PGC LC-MS can be used for the effective analysis of HS 
oligosaccharides, with good separation, sensitivity and isomeric resolution. The data also 
demonstrated that hydrophobic and electronic properties of PGC play major roles in binding to, 
and dissociation of HS oligosaccharides from graphite. As the electronic modifier is constant 
throughout the gradient, this elution must be based on the compounds hydrophobic nature; the 
more sulfates on a small chain the more hydrophilic it will be, and the larger or higher dp causes 
an increase in hydrophobicity which delays its elution. Based on this notion it would be 
reasonable to suggest that if a cation such as an ammonium ion was masking a negative charge, 
then this would affect the retention of a structure to the graphite. This was consistent with the 
observation that ammonium adduction results in longer elution times. PGC LC-MS of these 
oligosaccharides has improved the separation and analysis of negatively charged saccharides by 
exploiting oligosaccharide ring units and negative charges.  
PGC column separations can be challenging but also high resolving due to their ability to 
complex with analytes through hydrophobicity, anion exchange and changes in steric 
interactions, leading to unpredictable chromatography behaviour. In our studies we found that 
long equilibration times were required along with overnight storage in acetronitrile combined 
with an acid wash to prevent PGC oxidation and avoid inconsistent retention times. Retention 
times of the analyte can vary over time most likely due to column oxidation, utilising an acid 
wash improves the stability29, 47. Others have shown deterioration of the PGC columns over time, 
necessitating maintenance and regeneration procedures using tetrahydrofuran, acetone, 
trifluoroacetate, hydrochloric acid or sodium hydroxide29, 47. As long as the PGC column is 
maintained, high yields of oligosaccharides are achievable. Several articles have shown changes 
in retention time from PGC over hours, months and years29, 47-48 and we observed small retention 
time variation. It has been speculated that the PGC layers may rearranged, and the redox state of 
the material may also change. Oxidation of PGC appears to increase the positive charge on the 
surface causing stronger retention of anions; reduction of PGC resulted in a decrease in anionic 
binding which is important in the binding of highly sulfated oligosaccharides. Others have shown 
that treatment of the column with H2O2 and sodium thiosulphate maintained the column in a 
more stable redox state49. It has also been shown that temperature, percentage of methanol / 
acetronitrile, concentration of carbonate ions, pH and acid washes can all effect the elution of 
structures from PGC. Since pH can also effect analyte elution lowering the pH to pH 7 from pH 
7.7 with 10 mM ammonium bicarbonate would ensure that the peeling reaction of reducing 
disaccharides 3-O-sulfate residues does not occur50. We are currently exploring these options to 
improve and optimize PGC LCMS as a robust routine methodology for HS oligosaccharides, and 
further allow analysis on saccharides containing reducing terminal 3O-sulfate groups. 
To improve routine structural analyses, PGC could be coupled orthogonally with other 
LC-MS methods currently available. Both SEC and RP-IP can be easily performed before or 
after the PGC step, as both methodologies use compatible buffer systems. HILIC would be 
compatible with an additional organic line increasing the percentage of acetonitrile, (if the 
method was placed after PGC), or water (if placed before PGC). Coupling methods to create 
multi-dimensional workflows could significantly improve oligosaccharide separation in the 
future over currently available methods. 
Obtaining saccharides of sufficient purity and their definitive sequencing, are challenging 
problems within the HS field. This is due to the high proportion of isomeric structures present, 
and the direct effect of purity on the ability to sequence. HS saccharide sequencing is still a 
significant major challenge due to a large proportion of product ions being isomeric, especially 
as dp and sulfation increases. This is further complicated by potential sulfation loss. However, 
progress is being made, and the availability if fully defined HS structures prepared by chemical, 
enzymatic and chemoenzymatic syntheses is supporting furthering development in this area 40, 51-
52. As more pure oligosaccharides are sequenced it creates the possibility of database 
methodology through spectral matching and increased confidence in false discovery rate scoring. 
A method such as graphite LC-MS as demonstrated here, which provides high resolution 
separation of oligosaccharides and enhanced oligosaccharide purity, leads to simplified product 
ion spectra, improved confidence in sequence assignment, and provides a profiling tool for 
complex and isolated structures. Thus, these PGC-based methods should prove invaluable in 
understanding HS structure-activity relationships. 
 
Acknowledgements 
We acknowledge helpful comments from Prof David Fernig. Financial support for this research 
was provided by a PhD studentship to RM from the Medical Research Council (MRC) and 
Engineering and Physical Sciences Research (EPSRC) Council UK (UoL/MRC-EPSRC), a 
Senior Research Fellowship from the MRC to JET (G117/423), a Biotechnology and Biological 
Sciences Research Council project grant to JET (BB/I004343/1). NGK was supported by the 
Swedish Research Council (621-2013-5895), Kung Gustav V:s 80-års foundation, Petrus and 
Augusta Hedlund’s foundation and the AFA insurance research fund. 
 
Supporting Information Available: Figure S-1. SEC separation of heparinase I digested 
oligosaccharides produced from heparin. Figure S-2. LC-MS analysis of Arixtra. Figure S-3. 
Relative oligossaccharide abundance identified through LC-MS of SEC fraction A. Figure S-4. 
Relative oligossaccharide abundance identified through LC-MS of SEC fraction B. Figure S-5. 
Relative oligossaccharide abundance identified through LC-MS of SEC fraction C. Figure S-6. 
Relative oligossaccharide abundance identified through LC-MS of SEC fraction M. Figure S-7 
SAX separation of SEC fraction A. Figure S-8. Recovery of dp6 + 8SO3 from the graphite 
column. Table S-1. LC-MS analysis of SEC fraction A. Table S-2. LC-MS analysis of SEC 
fraction B. Table S-3. LC-MS analysis of SEC fraction C. Table S-4. LC-MS analysis of SEC 
fraction M. Table S-5 and Table S-6, theoretical product ions of Peak F and G. Table S-7 to 
Table S-18, theoretical product ions of Peak H. Table S-19 to Table S-36, theoretical product 
ions of Peaks I, J, K, and L. Table S-37, summary of total theoretical product ions of Peaks I, J, 
K, and L. Table S-38, theoretical product ions of Peak O. Supporting information (45 pages). 
This material is available free of charge via the Internet at http://pubs.acs.org. 
 
Figure 1. Workflow of oligosaccharide purification and PGC LC-MS analysis.  
 
Figure 2. A high throughput method employing PGC LC-MS for analysis of 
oligosaccharides derived from PMHS. Each fraction was SEC separated (Figure S-1) and 
analysed using PGC LC-MS and MS/MS as a method for the analysis of several structures in a 
mixture. 2a) Separation of SEC fraction A using PGC LC-MS. 2b) Separation of SEC fraction B 
using PGC LC-MS. 2c) Separation of SEC fraction C using PGC LC-MS. The gradient in all 
cases was a 0-40% linear acetonitrile gradient with 10 mM ammonium bicarbonate. 
 
Figure 3. Analysis of purified HS saccharides by PGC LC-MS. A SEC dp4 fraction (peak A, 
Figure S-1) was separated using SAX chromatography on a 0-2 M gradient over 150 mins 
(Figure S-2) and analysed through PGC LC-MS/MS. 3a) LC-MS of peak D and E. 3b) MS 
spectra of peaks F and G are shown on the bottom chromatogram with both peaks displaying an 
[M – H] – ion of m/z 795.2 and MS spectrum of peak H is shown in the top spectra displaying an 
[M – 2H]2- of m/z 477. 3c) MS/MS of the [M – H]- ion of m/z 795 from peak F corresponding to 
the structure ΔUA – GlcNS – UA – GlcNAc.  3d) MS/MS of the [M – H]- ion of m/z 795 from 
peak G corresponding to the structure ΔUA – GlcNAc – UA – GlcNS. 3e) MS/MS of the [M – 
2H]2- ion of m/z 477 from peak H corresponding to the structure ΔUA – GlcNS – UA2S – 
GlcNAc6S. All fragments were assigned using Domon and Costello nomenclature using the 
Glycoworkbench software 38.   
 
Figure 4. Extracted ion chromatogram of dp6 + 1Ac + 3SO3 from Figure 2b. An EIC shows 
that PGC could separate isomeric structures isolated from SEC fraction B, which is a complex 
mixture of dp6 and dp8 oligosaccharides. 4a) EIC of [M – 2H]2- ion of m/z 645.5 corresponding 
to a dp6 + 1Ac + 3SO3. 2b) MS/MS of peak I (18 mins) corresponding to the structure ∆UA2S - 
GlcNS - UA - GlcNS - UA - GlcNAc. 2c) MS/MS of peak J (20 mins) corresponding to the 
structure ∆UA2S - GlcNS - UA - GlcNAc - UA - GlcNS. 3d) MS/MS of peak K (21mins) 
corresponding to the structure ∆UA – GlcNS6S - UA - GlcNS - UA - GlcNAc. 2e) MS/MS of 
peak L (22 mins) corresponding to the structure ∆UA - GlcNS - UA - GlcNAc - UA – GlcNS6S.  
 
Figure 5. Trisaccharide structures identified using LC-MS of PMHS digested products. 
Products of a heparinase III enzyme digest of PMHS were separated using SEC. Fraction M was 
separated and analysed using graphite LC-MS and MS/MS. 5a) Separation of fraction M using 
PGC LC-MS on a 0-40 % gradient using acetonitrile with 10 mM ammonium bicarbonate. Insert 
- MS of peak O, an ambiguous compound having an [M – H]- ion of m/z 592.1. 5c) MS/MS of 
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Figure 1. Workflow of oligosaccharide purification and PGC LC-MS analysis.  
  
 



































































Figure 2. A high throughput method employing PGC LC-MS for analysis of 
oligosaccharides derived from PMHS.  
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Figure 4. Extracted ion chromatogram of dp6 + 1Ac + 3SO3 from figure 2b.  
 





































































Figure 5. Trisaccharide structures identified using LC-MS of PMHS digested products. 
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Figure S-1. Products of a heparinase III enzyme digest of PMHS were separated using SEC and 
selected fractions as shown collected for further experiments.  
 
 m/z




















Figure S-2. PGC LC-MS analysis of Arixtra. a) PGC LC-MS of Arixtra on a 0-40 % gradient 
resulted in the elution of Arixtra at 16.1 minutes from the EIC. b) MS of Arixtra at 16.1 minutes.  
 
 Table S-1. PGC LC-MS analysis of SEC fraction A obtained from heparinase III digested 
PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution 
order. The oligosaccharide style established by Zaia et al was used in oligosaccharide 
characterization, as follows; [ΔHexA, HexA, GlcN, SO3, Ac, Na, NH3].  
 
Time (mins) m/z [ΔHexA, HexA, GlcN, 
SO3, Ac, Na, NH3] 
Composition  
17-18 955 [M-H]-, 477.0 [M-2H]2- 1, 1, 2, 3, 1, 0, 0 dp4 +Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
18-19 1292 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 955 [M-H]-, 477.0 [M-2H]2- 1, 1, 2, 3, 1, 0, 0 dp4 +Ac + 3SO3 
 1035 [M-H]-, 517.0 [M-2H]2- 1, 1, 2, 4, 1, 0, 0 dp4 + Ac + 4SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
19-20 955 [M-H]-, 477.0 [M-2H]2 1, 1, 2, 3, 1, 0, 0 dp4 +Ac + 3SO3 
 993 [M-H]-, 496.0 [M-2H]2- 1, 1, 2, 4, 0, 0, 0 dp4 + 4SO3 
 1212.2 [M-H]- 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
20-21 955 [M-H]-, 477.0 [M-2H]2 1, 1, 2, 3, 1, 0, 0 dp4 +Ac + 3SO3 
 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330.2 [M-H]-, 664.6 [M-2H]2- 1, 2, 3, 4, 0, 0, 0 dp6 + 4SO3 
21-22 1170.2 [M-H]-, 584.6 [M-2H]2- 1, 2, 3, 2, 0, 0, 0 dp6 + 2SO3 
 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330.2 [M-H]-, 664.6 [M-2H]2- 1, 2, 3, 4, 0, 0, 0 dp6 + 4SO3 
22-23 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1212.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
23-24 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1132.2 [M-H]-, 565.6 [M-2H]2- 1, 2, 3, 1, 1, 0, 0 dp6 + Ac + 1SO3 
 1170.2 [M-H]-, 584.6 [M-2H]2- 1, 2, 3, 2, 0, 0, 0 dp6 + 2SO3 
 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1234.2 [M-H]-, 616.6 [M-2H]2- 1, 2, 3, 2, 1, 1, 0 dp6 + Ac + 2SO3 + 1Na 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330.2 [M-H]-, 664.6 [M-2H]2- 1, 2, 3, 4, 0, 0, 0 dp6 + 4SO3 
 1356.2 [M-H]-, 677.2 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
24-25 1132.2 [M-H]-, 565.6 [M-2H]2- 1, 2, 3, 1, 1, 0, 0 dp6 + Ac + 1SO3 
 1170.2 [M-H]-, 584.6 [M-2H]2- 1, 2, 3, 2, 0, 0, 0 dp6 + 2SO3 
 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1356.2 [M-H]-, 677.2 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
25-26 1019 [M-H]-, 509.0 [M-2H]2- 1, 1, 2, 3, 2, 1, 0 dp4 + 2Ac + 3SO3 + 1Na 
 1116.2 [M-H]-, 557.6 [M-2H]2-  1, 2, 3, 0, 2, 1, 0 dp6 + 2Ac + 1Na 
 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1276.2 [M-H]-, 637.6 [M-2H]2- 1, 2, 3, 2, 2, 1, 0 dp6 + 2Ac + 2SO3 + 1Na 
 1356.2 [M-H]-, 677.2 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
26-27 1356.2 [M-H]-, 677.2 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
27-28  1136.2 [M-H]-, 578.6 [M-2H]2- 1, 2, 3, 0, 3, 1, 0 dp6 + 3Ac + 1Na 
 1170.2 [M-H]-, 584.6 [M-2H]2-  1, 2, 3, 2, 0, 0, 0 dp6 + 2SO3 
 1276.2 [M-H]-, 637.6 [M-2H]2- 1, 2, 3, 2, 2, 1, 0 dp6 + 2Ac + 2SO3 + 1Na 
 1294 [M-H]-, 646.5 [M-2H]2- 1, 2, 3, 3, 0, 2, 0 dp6 + 3SO3 + 2Na 






Figure S-3. Relative abundance of each oligosaccharide identified through PGC-LC-MS of SEC fraction A obtained from heparinase 
III digested PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution order. The oligosaccharide 
style is as described in Table S-1. 
 
Table S-2. PGC LC-MS analysis of SEC fraction B obtained from heparinase III digested 
PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution 
order. The oligosaccharide style is as described in Table S-1.  
 
Time (mins) m/z  [ΔHexA, HexA, GlcN, 
SO3, Ac, Na, NH3] 
Composition 
17-18 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
18-19 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
19-20 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1410 [M-H]-, 704.5 [M-2H]2- 1, 2, 3, 5, 0, 0, 0 dp6 + 5SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
20-21 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1410 [M-H]-, 704.5 [M-2H]2- 1, 2, 3, 5, 0, 0, 0 dp6 + 5SO3 
21-22 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1356 [M-H]-, 677.5 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1414.2 [M-H]-, 706.6 [M-2H]2- 1, 2, 3, 4, 2, 0, 0 dp6 + 2Ac + 4SO3 
 1436 [M-H]-, 717.5 [M-2H]2- 1, 2, 3, 4, 2, 1, 0 dp6 + 2Ac + 4SO3 + 1Na 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
22-23 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
23-24 1212. [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1232 [M-H]-, 615.5 [M-2H]2- 1, 2, 3, 1, 3, 0, 1 dp6 + 3Ac + 1SO3 + 1NH3 
 1254.2 [M-H]-, 626.6 [M-2H]2- 1, 2, 3, 2, 2, 0, 0 dp6 + 2Ac + 2SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330.2 [M-H]-, 664.6 [M-2H]2- 1, 1, 2, 4, 0, 0, 0 dp4 + 4SO3 
 1356 [M-H]-, 677.5 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1469 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + 1SO3 
24-25 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1276 [M-H]-, 637.5 [M-2H]2- 1, 2, 3, 2, 2, 1, 0 dp6 + 2Ac + 2SO3 + 1Na 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1356 [M-H]-, 677.5 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
 1392.2 [M-H]-, 695.6 [M-2H]2- 1, 2, 3, 3, 3, 0, 1 dp6 + 3Ac + 3SO3 + 1NH3 
 1436 [M-H]-, 717.5 [M-2H]2- 1, 2, 3, 4, 2, 1, 0 dp6 + 2Ac + 4SO3 + 1Na 
 1469 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + 1SO3 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
25-26 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1276 [M-H]-, 637.5 [M-2H]2- 1, 2, 3, 2, 2, 1, 0 dp6 + 2Ac + 2SO3 + 1Na 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1356 [M-H]-, 677.5 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
 1363.4 [M-H]-, 681.2 [M-2H]2- 1, 3, 4, 0, 0, 0, 1 dp8 + 1NH3 
 1405.4 [M-H]-, 703.2 [M-2H]2- 1, 3, 4, 0, 1, 0, 1 dp8 + Ac + 1NH3 
 1427.4 [M-H]-, 713.2 [M-2H]2- 1, 3, 4, 1, 0, 0, 0 dp8 + 1SO3  
 1469 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + 1SO3 
 1489 [M-H]-, 744.1 [M-2H]2- 1, 3, 4, 0, 3, 0, 1 dp8 + 3Ac + 1NH3 
26-27 1212.2 [M-H]-, 605.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 0 dp6 + Ac + 2SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1276 [M-H]-, 637.5 [M-2H]2- 1, 2, 3, 2, 2, 1, 0 dp6 + 2Ac + 2SO3 + 1Na 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1356 [M-H]-, 677.5 [M-2H]2- 1, 2, 3, 3, 2, 1, 0 dp6 + 2Ac + 3SO3 + 1Na 
 1363.4 [M-H]-, 681.2 [M-2H]2- 1, 3, 4, 0, 0, 0, 1 dp8 + 1NH3 
 1389.4 [M-H]-, 694.2 [M-2H]2- 1, 3, 4, 0, 1, 0, 0 dp8 + Ac 
 1405.4 [M-H]-, 702.2 [M-2H]2- 1, 3, 4, 0, 1, 0, 1 dp8 + Ac + 1NH3 
27-28 1106 [M-H]-, 552.6 [M-2H]2- 1, 2, 3, 1, 0, 0, 1 dp6 + 1SO3 + 1NH3 
 1170.2 [M-H]-, 584.6 [M-2H]2- 1, 2, 3, 2, 0, 0, 0 dp6 + 2SO3 
 1228.2 [M-H]-, 613.6 [M-2H]2- 1, 2, 3, 2, 1, 0, 1 dp6 + Ac + 2SO3 + 1NH3 
 1250.7 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1347.4 [M-H]-, 673.2 [M-2H]2- 1, 3, 4, 0, 0, 0, 0 dp8 





Figure S-4. Relative abundance of each oligosaccharide identified through PGC-LC-MS of SEC fraction B obtained from heparinase 
III digested PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution order. The oligosaccharide 
style is as described in Table S-1. 
 
Table S-3. PGC LC-MS analysis of SEC fraction C obtained from heparinase III digested 
PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution 




m/z [ΔHexA, HexA, GlcN, 
SO3, Ac, Na, NH3] 
Composition 
17-18 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
18-19 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
19-20 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
20-21 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330 [M-H]-, 664.5 [M-2H]2- 1, 2, 3, 4, 0, 0, 0 dp6 + 4SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1410.2 [M-H]-, 704.6 [M-2H]2- 1, 2, 3, 5, 0, 0, 0 dp6 + 5SO3 
 1414.2 [M-H]-, 706.6 [M-2H]2- 1, 2, 3, 4, 2, 0, 0 dp6 + 2Ac + 4SO3 
 1629.2 [M-H]-, 814.1 [M-2H]2- 1, 3, 4, 3, 1, 0, 0 dp8 + Ac + 3SO3 
 1667.2 [M-H]-, 833.1 [M-2H]2- 1, 3, 4, 4, 0, 0, 0 dp8 + 4SO3 
 1709.2 [M-H]-, 854.1 [M-2H]2- 1, 3, 4, 4, 1, 0, 0 dp8 + Ac + 4SO3 
21-22 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1414.2 [M-H]-, 706.6 [M-2H]2- 1, 2, 3, 4, 2, 0, 0 dp6 + 2Ac + 4SO3 
 1436.2 [M-H]-, 717.6 [M-2H]2- 1, 2, 3, 4, 2, 1, 0 dp6 + 2Ac + 4SO3 + 1Na 
 1452 [M-H]-, 725.5 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
 1709.2 [M-H]-, 854.1 [M-2H]2- 1, 3, 4, 4, 1, 0, 0 dp8 + Ac + 4SO3 
 1751.2 [M-H]-, 875.1 [M-2H]2- 1, 3, 4, 4, 2, 0, 0 dp8 + 2Ac + 4SO3 
 1789.2 [M-H]-, 894.1 [M-2H]2- 1, 3, 4, 5, 1, 0, 0 dp8 + Ac + 5SO3 
22-23 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1414.2 [M-H]-, 706.6 [M-2H]2- 1, 2, 3, 4, 2, 0, 0 dp6 + 2Ac + 4SO3 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
 1629.2 [M-H]-, 814.2 [M-2H]2- 1, 3, 4, 3, 1, 0, 0 dp8 + Ac + 3SO3 
 1691.2 [M-H]-, 845.1 [M-2H]2- 1, 3, 4, 2, 4, 0, 1 dp8 + 4Ac + 2SO3 + 1NH3 
 1709.2 [M-H]-, 854.1 [M-2H]2- 1, 3, 4, 4, 1, 0, 0 dp8 + Ac + 4SO3 
23-24 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1330.2 [M-H]-, 664.6 [M-2H]2- 1, 2, 3, 4, 0, 0, 0 dp6 + 4SO3 
 1352.2 [M-H]-, 675.6 [M-2H]2- 1, 2, 3, 4, 0, 1, 0 dp6 + 4SO3 + 1Na 
 1372.2 [M-H]-, 685.6 [M-2H]2- 1, 2, 3, 4, 1, 0, 0 dp6 + Ac + 4SO3 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
 1629.2 [M-H]-, 814.2 [M-2H]2- 1, 3, 4, 3, 1, 0, 0 dp8 + Ac + 3SO3 
24-25 1292.2 [M-H]-, 645.6 [M-2H]2- 1, 2, 3, 3, 1, 0, 0 dp6 + Ac + 3SO3 
 1250.2 [M-H]-, 624.6 [M-2H]2- 1, 2, 3, 3, 0, 0, 0 dp6 + 3SO3 
 1314 [M-H]-, 656.5 [M-2H]2- 1, 2, 3, 3, 1, 1, 0 dp6 + Ac + 3SO3 + 1Na 
 1334.2 [M-H]-, 666.6 [M-2H]2- 1, 2, 3, 3, 2, 0, 0 dp6 + 2Ac + 3SO3 
 1376.2 [M-H]-, 687.6 [M-2H]2- 1, 2, 3, 3, 3, 0, 0 dp6 + 3Ac + 3SO3 
 1452.2 [M-H]-, 725.6 [M-2H]2- 1, 2, 3, 5, 1, 0, 0 dp6 + Ac + 5SO3 
 1456.2 [M-H]-, 727.6 [M-2H]2- 1, 2, 3, 4, 3, 0, 0 dp6 + 3Ac + 4SO3 
 1469 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + SO3 
 1507.4 [M-H]-, 753.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 0 dp8 + 2SO3 
 1587.4 [M-H]-, 793.1 [M-2H]2- 1, 3, 4, 3, 0, 0, 0 dp8 + 3SO3 
 1629.2 [M-H]-, 814.2 [M-2H]2- 1, 3, 4, 3, 1, 0, 0 dp8 + Ac + 3SO3 
 1633.2 [M-H]-, 816.1 [M-2H]2- 1, 3, 4, 2, 3, 0, 0 dp8 + 3Ac + 2SO3 
 1667.2 [M-H]-, 833.1 [M-2H]2- 1, 3, 4, 4, 0, 0, 0 dp8 + 4SO3 
 1709.2 [M-H]-, 854.1 [M-2H]2- 1, 3, 4, 4, 1, 0, 0 dp8 + Ac + 4SO3 
 1793.2 [M-H]-, 896.1 [M-2H]2- 1, 3, 4, 4, 3, 0, 0 dp8 + 3Ac + 4SO3 
25-26 1469.4 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + SO3 
 1485.4 [M-H]-, 742.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 1 dp8 + Ac + SO3 + 1NH3 
 1511.4 [M-H]-, 755.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + 1SO3 
 1549.4 [M-H]-, 774.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 0 dp8 + Ac + 2SO3 
 1587.4 [M-H]-, 793.1 [M-2H]2- 1, 3, 4, 3, 0, 0, 0 dp8 + 3SO3 
 1629.2 [M-H]-, 814.2 [M-2H]2- 1, 3, 4, 3, 1, 0, 0 dp8 + Ac + 3SO3 
 1709.2 [M-H]-, 854.1 [M-2H]2- 1, 3, 4, 4, 1, 0, 0 dp8 + Ac + 4SO3 
27-28 1389 [M-H]-, 694.2 [M-2H]2- 1, 3, 4, 0, 1, 0, 0 dp8 + Ac 
 1507.4 [M-H]-, 753.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 0 dp8 + 2SO3 
 1675.2 [M-H]-, 837.1 [M-2H]2- 1, 3, 4, 2, 4, 0, 0 dp8 + 4Ac + 2SO3 
28-29 1447.2 [M-H]-, 723.2 [M-2H]2- 1, 3, 4, 0, 2, 0, 1 dp8 + 2Ac + 1NH3 
 1469.4 [M-H]-, 734.2 [M-2H]2- 1, 3, 4, 1, 1, 0, 0 dp8 + Ac + SO3 
 1507.4 [M-H]-, 753.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 0 dp8 + 2SO3 
29-30 1447.2 [M-H]-, 723.2 [M-2H]2- 1, 3, 4, 0, 2, 0, 1 dp8 + 2Ac + 1NH3 
 1507.4 [M-H]-, 753.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 0 dp8 + 2SO3 
 1565.4 [M-H]-, 782.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 1 dp8 + Ac + 2SO3 + 1NH3 
30-31 1427 [M-H]-, 721.2 [M-2H]2- 1, 3, 4, 1, 0, 0, 1 dp8 + 1SO3 + 1NH3 
 1427.4 [M-H]-, 732.2 [M-2H]2- 1, 3, 4, 1, 0, 1, 1 dp8 + 1SO3 + 1NH3 + 1Na 
 1485.4 [M-H]-, 742.2 [M-2H]2- 1, 3, 4, 1, 0, 0, 1 dp8 + Ac + 1SO3 + 1NH3 
 1507.4 [M-H]-, 753.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 0 dp8 + 2SO3 
 1523.4 [M-H]-, 761.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 1 dp8 + 2SO3 + 1NH3 
 1565.4 [M-H]-, 782.2 [M-2H]2- 1, 3, 4, 2, 1, 0, 1 dp8 + Ac + 2SO3 + 1NH3 
31-32 1347.4 [M-H]-, 681.2 [M-2H]2- 1, 3, 4, 0, 0, 0, 0 dp8 
 1405.4 [M-H]-, 702.2 [M-2H]2- 1, 3, 4, 0, 1, 0, 1 dp8 + Ac + 1NH3 
 1427 [M-H]-, 721.2 [M-2H]2- 1, 3, 4, 1, 0, 0, 1 dp8 + 1SO3 + 1NH3 
 1523.4 [M-H]-, 761.2 [M-2H]2- 1, 3, 4, 2, 0, 0, 1 dp8 + 2SO3 + 1NH3 










Figure S-5. Relative abundance of each oligosaccharide identified through PGC-LC-MS of SEC fraction C obtained from heparinase 
III digested PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution order. The oligosaccharide 
style is as described in Table S-1. 
Table S-4. PGC LC-MS analysis of SEC fraction M obtained from heparinase III digested 
PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution 
order. The oligosaccharide style is as described in Table S-1.  
Time 
(min) 
m/z [ΔHexA, HexA, GlcN, 
SO3, Ac, Na, NH3] 
Composition 
16-17 592.1 [M-H]- 1, 1, 1, 1, 0, 0, 0 dp3 + 1SO3 
 599.3 [M-H]- 0, 1, 2, 1, 0, 1, 0 GlcN-Ido-GlcN + 1SO3 + 1Na 
 608.1 [M-H]- 1, 1, 1, 1, 0, 0, 1 dp3 + 1SO3 + 1NH3 
17-18 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3 
 592.1 [M-H]- 1, 1, 1, 1, 0, 0, 0 dp3 + 1SO3 
18-19 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3 
 515.1 [M-H]- 0, 1, 2, 0, 0, 0, 0 GlcN-Ido-GlcN 
 554.1 [M-H]- 1, 0, 1, 2, 1, 0, 1 dp2 + 1Ac + 2SO3 + 1NH3 
19-20 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3  
 515.1 [M-H]- 0, 1, 2, 0, 0, 0, 0 GlcN-Ido-GlcN 
20-21 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3  
21-22 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3  
22-23 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3  
23-24 458.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3  
 476.1 [M-H]- 1, 0, 1, 1, 1, 0, 0 dp2 + 1Ac + 1SO3 
 497.1 [M-H]-  0, 1, 2, 0, 0, 0, 0 GlcN-Ido-GlcN 
 673.3 [M-H]- 1, 1, 2, 0, 0, 0, 0 dp4 
 715.3 [M-H]- 1, 1, 1, 2, 1, 0, 1 dp3 + 1Ac + 2SO3 + 1NH3 
24-25 497.1 [M-H]-  0, 1, 2, 0, 0, 0, 0 GlcN-Ido-GlcN 
 673.3 [M-H]- 1, 1, 2, 0, 0, 0, 0 dp4 
 715.3 [M-H]- 1, 1, 1, 2, 1, 0, 1 dp3 + 1Ac + 2SO3 + 1NH3 
 753.2 [M-H]- 1, 1, 2, 1, 0, 0, 0 dp4 + 1SO3 
 
 
Figure S-6. Relative abundance of each oligosaccharide identified through PGC-LC-MS of SEC fraction M obtained from heparinase 
III digested PMHS. Compounds were identified based on MS and MS/MS spectra and placed in elution order. The oligosaccharide 














Figure S-7. SEC fraction A was further separated using SAX HPLC. Peaks D and E were 
selected for analysis via PGC LC-MS to determine their structural sequence and purity.  
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Figure S-8. Yields obtained from PGC column using a dp6 + 8SO3 purified heparin 
oligosaccharide. a) 4µg of dp6 + 8SO3 in water was loaded onto an analytical PGC column, 
the sample from 20 – 23 minutes was collected. b) The collected dp6 + 8SO3 was dried by 
centrifugal evaporation down to 200 µl to remove any acetronitrile and ammonium 
bicarbonate. The sample was further diluted in ddH20 and reloaded onto the graphite column 






Table S-5: A table representation of the B, Y, C and Z ions theoretically identified from one 





    1- 2-  Peak F Peak G 
B1 158.02 157.01 78.00 x x 
B2 399.04 398.03 198.51 x x 
B3 575.07 574.06 286.53 ✓ x 
  
     Y1 221.09 220.08 109.54 x x 
Y2 397.12 396.11 197.55 ✓ x 
Y3 638.14 637.13 318.06 ✓ ✓
  
     C1 176.03 175.02 87.01 x x 
C2 417.05 416.04 207.52 ✓ ✓
C3 593.08 592.07 295.53 ✓ x 
  
     Z1  203.07 202.06 100.53 x x 
Z2 379.11 378.10 188.55 ✓ ✓
Z3 620.13 619.12 309.06 ✓ x 
Table S-6: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA - GlcNS. 
    1- 2- Peak F Peak G 
B1 158.02 157.01 78.00 x x 
B2 361.10 360.09 179.54 x x 
B3 537.13 536.12 267.56 x ✓
  
     Y1 259.03 258.02 128.51 x ✓
Y2 435.06 434.05 216.52 x ✓
Y3 638.14 637.13 318.06 ✓ ✓
  
     C1 176.00 174.99 86.99 x x 
C2 379.11 378.10 188.55 ✓ ✓
C3 555.14 554.13 276.56 x ✓
  
     Z1 241.02 240.02 119.51 x ✓
Z2 417.05 416.04 207.52 ✓ ✓




Table S-7: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA2S - GlcNAc6S 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 399.04 398.03 198.51 ✓
B3 655.03 654.02 326.51 ✓
  
    C1 176.03 175.02 87.01 x 
C2 417.05 416.04 207.52 ✓
C3 673.04 672.03 335.51 x 
  
    Y1 301.04 300.03 149.51 ✓
Y2 557.03 556.02 277.51 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 283.03 282.02 140.51 ✓
Z2 539.02 538.01 268.50 ✓




Table S-8: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNS - UA - GlcNAc6S 
(peak H). 
 
    1- 2- Peak H  
B1 237.97 236.96 117.98 x 
B2 479.00 477.99 238.49 x 
B3 655.03 654.02 326.51 ✓
  
    C1 255.98 254.97 126.98 ✓
C2 497.01 496.00 247.50 x 
C3 673.04 672.03 335.51 x 
  
    Y1 301.04 300.03 149.51 ✓
Y2 477.07 476.06 237.53 x 
Y3 718.10 717.09 358.04 x 
  
    Z1 283.03 282.02 140.51 ✓
Z2 459.06 458.05 228.52 ✓




Table S-9: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS6S - UA - GlcNAc6S 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 479.00 477.99 238.49 x 
B3 655.03 654.02 326.51 ✓
  
    C1 176.03 175.02 87.01 x 
C2 497.01 496.00 247.50 x 
C3 673.04 672.03 335.51 x 
  
    Y1 301.04 300.03 149.51 ✓
Y2 477.07 476.06 237.53 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 283.03 282.02 140.51 ✓
Z2 459.06 458.05 228.52 ✓
Z3 780.05 779.04 389.02 ✓
 
 
Table S-10: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS6S - UA2S - GlcNAc 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 479.00 477.99 238.49 x 
B3 734.99 733.98 366.49 x 
  
    C1 176.03 175.02 87.01 x 
C2 497.01 496.00 247.50 x 
C3 753.00 751.99 375.49 x 
  
    Y1 221.09 220.08 109.54 x 
Y2 477.07 476.06 237.53 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 203.07 202.06 100.53 x 
Z2 459.06 458.05 228.52 ✓
Z3 780.05 779.04 389.02 ✓
 
Table S-11: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNS - UA2S - GlcNAc 
(peak H). 
 
    1- 2- Peak H 
B1 237.97 236.96 117.98 x 
B2 479.00 477.99 238.49 x 
B3 734.99 733.98 366.49 x 
  
    C1 255.98 254.97 126.98 ✓
C2 497.01 496.00 247.50 x 
C3 753.00 751.99 375.49 x 
  
    Y1 221.09 220.08 109.54 x 
Y2 477.07 476.06 237.53 x 
Y3 718.10 717.09 358.04 x 
  
    Z1 203.07 202.06 100.53 x 
Z2 459.06 458.05 228.52 ✓
Z3 700.09 699.08 349.04 x 
 
Table S-12: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNS6S - UA - GlcNAc 
(peak H). 
 
    1- 2- Peak H 
B1 237.97 236.96 117.98 x 
B2 558.96 557.95 278.47 x 
B3 734.99 733.98 366.49 x 
  
    C1 255.98 254.97 126.98 ✓
C2 576.97 575.96 287.48 x 
C3 753.00 751.99 375.49 x 
  
    Y1 221.09 220.08 109.54 x 
Y2 397.12 396.11 197.55 ✓
Y3 718.10 717.09 358.04 x 
  
    Z1 203.07 202.06 100.53 x 
Z2 379.11 378.10 188.55 x 
Z3 700.09 699.08 349.04 x 
 
Table S-13: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA2S - GlcNS6S 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 361.10 360.09 179.54 x 
B3 617.08 616.07 307.53 x 
  
    C1 176.03 175.02 87.01 x 
C2 379.11 378.10 188.55 x 
C3 635.10 634.09 316.54 x 
  
    Y1 338.99 337.98 168.49 ✓
Y2 594.98 593.97 296.48 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 320.98 319.97 159.48 x 
Z2 576.97 575.96 287.48 x 
Z3 780.05 779.04 389.02 ✓
 
Table S-14: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc6S - UA - GlcNS6S 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 441.05 440.04 179.54 x 
B3 617.08 616.07 307.53 x 
  
    C1 176.03 175.02 87.01 x 
C2 459.06 458.05 188.55 ✓
C3 635.10 634.09 316.54 x 
  
    Y1 338.99 337.98 168.49 ✓
Y2 515.02 514.01 296.48 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 320.98 319.97 159.48 x 
Z2 497.01 496.00 287.48 x 
Z3 780.05 779.04 389.02 ✓
 
Table S-15: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNAc - UA - GlcNS6S 
(peak H). 
 
    1- 2- Peak H 
B1 237.97 236.96 117.98 x 
B2 441.05 440.04 219.52 x 
B3 617.08 616.07 307.53 x 
  
    C1 255.98 254.97 126.98 ✓
C2 459.06 458.05 228.52 ✓
C3 635.10 634.09 316.54 x 
  
    Y1 338.99 337.98 168.49 ✓
Y2 515.02 514.01 256.50 x 
Y3 718.10 717.09 358.04 x 
  
    Z1 320.98 319.97 159.48 x 
Z2 497.01 496.00 247.50 x 
Z3 700.09 699.08 349.04 x 
 
 
Table S-16: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNAc - UA2S - GlcNS 
(peak H). 
 
    1- 2- Peak H 
B1 237.97 236.96 117.98 x 
B2 441.05 440.04 219.52 x 
B3 697.04 696.03 347.51 x 
  
    C1 255.98 254.97 126.98 ✓
C2 459.06 458.05 228.52 ✓
C3 715.05 714.04 356.52 x 
  
    Y1 259.03 258.02 128.51 x 
Y2 515.02 514.01 256.50 x 
Y3 718.10 717.09 358.04 x 
  
    Z1 241.02 240.01 119.50 x 
Z2 497.01 496.00 247.50 x 
Z3 700.09 699.08 349.04 x 
 
Table S-17: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc6S - UA2S - GlcNS 
(peak H). 
 
    1- 2- Peak H 
B1 158.02 157.01 78.00 ✓
B2 441.05 440.04 219.52 x 
B3 697.04 696.03 347.51 x 
  
    C1 176.03 175.02 87.01 x 
C2 459.06 458.05 228.52 ✓
C3 715.05 714.04 356.52 x 
  
    Y1 259.03 258.02 128.51 x 
Y2 515.02 514.01 256.50 x 
Y3 798.06 797.05 398.02 x 
  
    Z1 241.02 240.01 119.50 x 
Z2 497.01 496.00 247.50 x 





Table S-18: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNAc6S - UA - GlcNS 
(peak H). 
 
    1- 2- Peak H  
B1 237.97 236.96 117.98 x 
B2 521.01 520.00 259.50 x 
B3 697.04 696.03 347.51 x 
  
    C1 255.98 254.97 126.98 ✓
C2 539.02 538.01 268.50 ✓
C3 715.05 714.04 356.52 x 
  
    Y1 259.03 258.02 128.51 x 
Y2 435.06 434.05 216.52 x 
Y3 718.10 717.09 358.04 x 
  
    Z1 241.02 240.01 119.50 x 
Z2 417.05 416.04 207.52 ✓
Z3 700.09 699.08 349.04 x 
 
Table S-19: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNS - UA - GlcNS - UA 
– GlcNAc. 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 237.97 236.96 117.99 x x x ✓
B2 479.00 477.99 238.50 ✓ x x x 
B3 655.03 654.02 326.52 x x x x 
B4 896.06 895.05 447.03 ✓ x x x 
B5 1072.09 1071.08 535.05 x x x x 
  
       C1 255.98 254.97 126.99 x x x x 
C2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
C3 673.04 672.03 335.52 x x x x 
C4 914.07 913.06 456.04 x x x x 
C5 1090.10 1089.09 544.05 x x x x 
  
       Y1 221.09 220.08 109.55 x x x x 
Y2 397.12 396.11 197.56 ✓ x ✓ ✓
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 814.17 813.16 406.09 ✓ x ✓ ✓
Y5 1055.20 1054.19 526.60 ✓ ✓ x ✓
  
       Z1 203.07 202.06 100.54 x x x x 
Z2 379.11 378.10 188.56 ✓ ✓ ✓ x 
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 796.16 795.15 397.08 x x ✓ ✓
Z5 1037.19 1036.18 517.60 x ✓ x x 
        
   
Total B, 
Y C and 
Z 
fragments 8.00 6.00 6.00 6.00 
 
 
Table S-20: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS6S - UA - GlcNS - UA 
– GlcNAc 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 479.00 477.99 238.50 ✓ x x x 
B3 655.03 654.02 326.52 x x x x 
B4 896.06 895.05 447.03 ✓ x x x 
B5 1072.09 1071.08 535.05 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
C3 673.04 672.03 335.52 x x x x 
C4 914.07 913.06 456.04 x x x x 
C5 1090.10 1089.09 544.05 x x x x 
  
       Y1 221.09 220.08 109.55 x x x x 
Y2 397.12 396.11 197.56 ✓ x ✓ ✓
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 814.17 813.16 406.09 ✓ x ✓ ✓
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 203.07 202.06 100.54 x x x x 
Z2 379.11 378.10 188.56 ✓ ✓ ✓ x 
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 796.16 795.15 397.08 x x ✓ ✓
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 7.00 4.00 6.00 4.00 
 
 
Table S-21: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA2S - GlcNS - UA 
– GlcNAc. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x ✓ x x 
B3 655.03 654.02 326.52 x x x x 
B4 896.06 895.05 447.03 x x x x 
B5 1072.09 1071.08 535.05 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 673.04 672.03 335.52 x x x x 
C4 914.07 913.06 456.04 x x x x 
C5 1090.10 1089.09 544.05 x x x x 
  
       Y1 221.09 220.08 109.55 x x x x 
Y2 397.12 396.11 197.56 ✓ x ✓ ✓
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 203.07 202.06 100.54 x x x x 
Z2 379.11 378.10 188.56 ✓ ✓ ✓ x 
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 




Table S-22: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNS6S - UA 
- GlcNAc. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 896.06 895.05 447.03 ✓ x x x 
B5 1072.09 1071.08 535.05 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 914.07 913.06 456.04 x x x x 
C5 1090.10 1089.09 544.05 x x x x 
  
       Y1 221.09 220.08 109.55 x x x x 
Y2 397.12 396.11 197.56 ✓ x ✓ ✓
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 203.07 202.06 100.54 x x x x 
Z2 379.11 378.10 188.56 ✓ ✓ ✓ x 
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 5.00 2.00 3.00 5.00 
 
 
Table S-23: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNS - UA2S 
– GlcNAc. 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 816.10 815.09 407.05 x x ✓ x 
B5 1072.09 1071.08 535.05 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 834.11 833.10 416.06 x x x x 
C5 1090.10 1089.09 544.05 x x x x 
  
       Y1 221.09 220.08 109.55 x x x x 
Y2 477.07 476.06 237.54 ✓ ✓ ✓ ✓
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 203.07 202.06 100.54 x x x x 
Z2 459.06 458.05 228.53 x x x x 
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 2.00 3.00 5.00 
 
Table S-24: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNS - UA - 
GlcNAc6S. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 816.10 815.09 407.05 x x ✓ x 
B5 992.13 991.12 495.07 x ✓ x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 834.11 833.10 416.06 x x x x 
C5 1010.14 1009.13 504.07 x x x x 
  
       Y1 301.04 300.03 149.52 x x x x 
Y2 477.07 476.06 237.54 ✓ ✓ ✓ ✓
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 283.03 282.02 140.52 x x x x 
Z2 459.06 458.05 228.53 x x x x 
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 3.00 3.00 5.00 
 
Table S-25: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNS - UA - GlcNAc - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 237.97 236.96 117.99 x x x ✓
B2 479.00 477.99 238.50 x x x x 
B3 655.03 654.02 326.52 x x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 255.98 254.97 126.99 x x x x 
C2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
C3 673.04 672.03 335.52 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 814.17 813.16 406.09 ✓ x ✓ ✓
Y5 1055.20 1054.19 526.60 ✓ ✓ x ✓
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 796.16 795.15 397.08 x x ✓ ✓
Z5 1037.19 1036.18 517.60 x ✓ x x 
        
   
Total B, 
Y C and 
Z 
fragments 5.00 6.00 4.00 6.00 
 
 
Table S-26: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS6S - UA - GlcNAc - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 479.00 477.99 238.50 x x x x 
B3 655.03 654.02 326.52 x x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.00 174.99 87.00 x x x x 
C2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
C3 673.04 672.03 335.52 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 814.17 813.16 406.09 ✓ x ✓ ✓
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 796.16 795.15 397.08 x x ✓ ✓
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 




Table S-27: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA2S - GlcNAc - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 655.03 654.02 326.52 x x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 673.04 672.03 335.52 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 638.14 637.13 318.07 ✓ ✓ x x 
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 620.13 619.12 309.07 x ✓ ✓ x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 






Table S-28: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNAc6S - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 2.00 1.00 5.00 
 
Table S-29: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNAc - 
UA2S - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 778.15 777.14 388.08 x x x ✓
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 796.16 795.15 397.08 x x ✓ ✓
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 515.02 514.01 256.51 x x x x 
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 2.00 3.00 7.00 
 
Table S-30: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNS - UA - GlcNAc - UA 
- GlcNS6S. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 399.04 398.03 198.52 x x x x 
B3 575.07 574.06 286.54 x x x ✓
B4 778.15 777.14 388.08 x x x ✓
B5 954.19 953.18 476.10 x x x ✓
  
       C1 176.03 175.02 87.02 x x x x 
C2 417.05 416.04 207.53 ✓ ✓ x ✓
C3 593.08 592.07 295.54 x x x ✓
C4 796.16 795.15 397.08 x x ✓ ✓
C5 972.20 971.19 485.10 x x x x 
  
       Y1 338.99 337.98 168.50 x x x x 
Y2 515.02 514.01 256.51 x x x x 
Y3 718.10 717.09 358.05 ✓ x ✓ ✓
Y4 894.13 893.12 446.07 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 320.98 319.97 159.49 ✓ x x x 
Z2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
Z3 700.09 699.08 349.05 x x x x 
Z4 876.12 875.11 437.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 4.00 2.00 3.00 8.00 
 
Table S-31: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA2S - GlcNAc - UA - GlcNS - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 237.97 236.96 117.99 x x x x 
B2 441.05 440.04 219.53 x x x x 
B3 617.08 616.07 307.54 ✓ x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 255.98 254.97 126.99 x x x x 
C2 459.06 458.05 228.53 x x x x 
C3 635.10 634.09 316.55 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 676.09 675.08 337.05 x ✓ x x 
Y4 852.12 851.11 425.06 x x x x 
Y5 1055.20 1054.19 526.60 x x x x 
        Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 658.08 657.07 328.04 x x x x 
Z4 834.11 833.10 416.06 x x x x 
Z5 1037.19 1036.18 517.60 x ✓ x x 
        
   
Total B, 
Y C and 
Z 




Table S-32: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc6S - UA - GlcNS - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 441.05 440.04 219.53 x x x x 
B3 617.08 616.07 307.54 ✓ x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 459.06 458.05 228.53 x x x x 
C3 635.10 634.09 316.55 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 676.09 675.08 337.05 x ✓ x x 
Y4 852.12 851.11 425.06 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 658.08 657.07 328.04 x x x x 
Z4 834.11 833.10 416.06 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 2.00 2.00 0.00 1.00 
 
Table S-33: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA2S - GlcNS - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 361.10 360.09 179.55 x x x x 
B3 617.08 616.07 307.54 ✓ x x x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 379.11 378.10 188.56 ✓ ✓ ✓ x 
C3 635.10 634.09 316.55 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 676.09 675.08 337.05 x ✓ x x 
Y4 932.08 931.07 465.04 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x  x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 658.08 657.07 328.04 x x x x 
Z4 914.07 913.06 456.04 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 3.00 1.00 1.00 
Table S-34: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA - GlcNS6S - 
UA - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 361.10 360.09 179.55 x x x x 
B3 537.13 536.12 267.57 x x ✓ x 
B4 858.11 857.10 428.06 x x x x 
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 379.11 378.10 188.56 ✓ ✓ ✓ x 
C3 555.14 554.13 276.57 x x x x 
C4 876.12 875.11 437.06 x x x x 
C5 1052.15 1051.14 525.08 x x x x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 435.06 434.05 216.53 x x x x 
Y3 756.05 755.04 377.03 x x x x 
Y4 932.08 931.07 465.04 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 417.05 416.04 207.53 ✓ ✓ x ✓
Z3 738.04 737.03 368.02 x ✓ x x 
Z4 914.07 913.06 456.04 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 2.00 3.00 2.00 1.00 
 
Table S-35: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA - GlcNS - 
UA2S - GlcNS. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 361.10 360.09 179.55 x x x x 
B3 537.13 536.12 267.57 x x ✓ x 
B4 778.15 777.14 388.08 x x x ✓
B5 1034.14 1033.13 516.07 x x x x 
  
       C1 176.03 175.02 87.02 x x x x 
C2 379.11 378.10 188.56 ✓ ✓ ✓ x 
C3 555.14 554.13 276.57 x x x x 
C4 796.16 795.15 397.08 x x x x 
C5 1052.15 1051.14 525.08 x x ✓ x 
  
       Y1 259.03 258.02 128.52 x x x x 
Y2 515.02 514.01 256.51 x x x x 
Y3 756.05 755.04 377.03 x x x x 
Y4 932.08 931.07 465.04 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 241.02 240.01 119.51 x x x x 
Z2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
Z3 738.04 737.03 368.02 x ✓ x x 
Z4 914.07 913.06 456.04 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 2.00 3.00 4.00 2.00 
 
Table S-36: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure ∆UA - GlcNAc - UA - GlcNS - UA 
- GlcNS6S. 
 
    1- 2- 18 mins  20 mins 21 mins 22 mins 
B1 158.02 157.01 78.01 x x x x 
B2 361.10 360.09 179.55 x x x x 
B3 537.13 536.12 267.57 x x ✓ x 
B4 778.15 777.14 388.08 x x x ✓
B5 954.19 953.18 476.10 x x x ✓
  
       C1 176.03 175.02 87.02 x x x x 
C2 379.11 378.10 188.56 ✓ ✓ ✓ x 
C3 555.14 554.13 276.57 x x x x 
C4 796.16 795.15 397.08 x x x x 
C5 972.20 971.19 485.10 x ✓ x x 
  
       Y1 338.99 337.98 168.50 x x x x 
Y2 515.02 514.01 256.51 x x x x 
Y3 756.05 755.04 377.03 x x x x 
Y4 932.08 931.07 465.04 x x x x 
Y5 1135.16 1134.15 566.58 x x x x 
  
       Z1 320.98 319.97 159.49 ✓ x x x 
Z2 497.01 496.00 247.51 ✓ ✓ ✓ ✓
Z3 738.04 737.03 368.02 x ✓ x x 
Z4 914.07 913.06 456.04 x x x x 
Z5 1117.15 1116.14 557.58 x x x x 
        
   
Total B, 
Y C and 
Z 
fragments 3.00 4.00 3.00 3.00 
 
Table S-37: A table representation of the B, Y, C and Z ions theoretically identified from one 











∆UA2S - GlcNS - UA - GlcNS - UA - 
GlcNAc 8 6 6 6 
∆UA - GlcNS6S - UA - GlcNS - UA - 
GlcNAc 7 4 6 4 
∆UA - GlcNS - UA2S - GlcNS - UA - 
GlcNAc 4 5 3 2 
∆UA - GlcNS - UA - GlcNS6S - UA - 
GlcNAc 5 2 3 5 
∆UA - GlcNS - UA - GlcNS - UA2S - 
GlcNAc 3 2 3 5 
∆UA - GlcNS - UA - GlcNS - UA - 
GlcNAc6S 3 3 3 5 
  
    ∆UA2S - GlcNS - UA - GlcNAc - UA - 
GlcNS 5 6 4 6 
∆UA - GlcNS6S - UA - GlcNAc - UA - 
GlcNS 4 4 4 4 
∆UA - GlcNS - UA2S - GlcNAc - UA - 
GlcNS 3 4 1 2 
∆UA - GlcNS - UA - GlcNAc6S - UA - 
GlcNS 3 2 1 5 
∆UA - GlcNS - UA - GlcNAc - UA2S - 
GlcNS 3 2 3 7 
∆UA - GlcNS - UA - GlcNAc - UA - 
GlcNS6S 4 2 3 8 
  
    ∆UA2S - GlcNAc - UA - GlcNS - UA - 
GlcNS 2 3 0 1 
∆UA - GlcNAc6S - UA - GlcNS - UA - 
GlcNS 2 2 0 1 
∆UA - GlcNAc - UA2S - GlcNS - UA - 
GlcNS 3 3 1 1 
∆UA - GlcNAc - UA - GlcNS6S - UA - 
GlcNS 2 3 2 1 
∆UA - GlcNAc - UA - GlcNS - UA2S - 
GlcNS 2 3 4 2 
∆UA - GlcNAc - UA - GlcNS - UA - 











Table S-38: A table representation of the B, Y, C and Z ions theoretically identified from one 
glyosidic bond cleavage in the oligosaccharide structure UA - GlcNS - UA (peak O). 
 
    1- 2- Peak O 
B1 158.02 157.01 78.00 x 
B2 - SO3 319.09 318.08 158.54 ✓
B2  399.04 398.03 198.51 ✓
  
    C1 176.03 175.02 87.01 ✓
C2 - SO3 337.10 336.09 167.54 ✓
C2 417.05 416.04 207.52 ✓
  
    Y1 194.04 193.03 96.01 x 
Y2 - SO3 355.11 354.10 176.55 ✓
Y2 435.06 434.05 216.52 ✓
  
    Z1 176.03 175.02 87.01 ✓
Z2 - SO3 337.10 336.09 167.54 ✓
Z2 417.05 416.04 207.52 ✓
 
 
 
 
 
 
 
 
 
 
 
